Vitamin K2, Vascular Calcification, Insulin Resistance, and Cardiovascular Health: Examining the Evidence and the Importance of a Healthy Lifestyle

1. Introduction: Understanding the Growing Interest in Vitamin K2

Cardiovascular disease remains one of the most significant public health challenges worldwide. Conditions such as coronary artery disease, stroke, heart failure, and peripheral arterial disease can have serious consequences for individuals, families, and healthcare systems. Although advances in diagnosis and treatment have improved cardiovascular care, prevention remains essential. Researchers continue to investigate how nutrition, metabolic health, lifestyle habits, and specific micronutrients influence the development and progression of cardiovascular disease.

Among the nutrients attracting increasing scientific attention is vitamin K2, a member of the vitamin K family that may play a role in bone metabolism, calcium regulation, and vascular health. Unlike nutrients that are primarily associated with energy production or antioxidant activity, vitamin K participates in the activation of specific proteins involved in blood coagulation and the regulation of mineral deposition in tissues. These functions have led scientists to investigate whether adequate vitamin K status, particularly vitamin K2 intake, could help maintain healthy blood vessels and reduce the progression of vascular calcification.

Vascular calcification occurs when calcium-containing mineral deposits accumulate within the walls of blood vessels or on heart valves. This process is frequently associated with aging, chronic kidney disease, diabetes, and atherosclerotic cardiovascular disease. Historically, calcification was sometimes considered a passive consequence of calcium accumulation. Contemporary research, however, has demonstrated that vascular calcification is an actively regulated biological process involving vascular smooth muscle cells, inflammatory pathways, mineral metabolism, and several proteins that either promote or inhibit mineral deposition.

One of the proteins receiving considerable attention is matrix Gla protein (MGP), which depends on vitamin K for its biological activation. Properly activated MGP helps inhibit inappropriate mineral deposition in soft tissues, including blood vessels. This mechanism provides a plausible explanation for why researchers are investigating vitamin K2 as a potential supportive factor in cardiovascular health.

A second area of interest concerns insulin resistance, a metabolic condition in which the body's cells respond less effectively to insulin. Insulin resistance can contribute to elevated blood glucose levels, prediabetes, type 2 diabetes, and an increased risk of cardiovascular complications. Some studies suggest that vitamin K supplementation may influence insulin sensitivity, although the evidence is not yet sufficient to establish vitamin K2 as a treatment for metabolic disease.

Research published in 2024 has contributed to these discussions. A systematic review and meta-analysis examining vitamin K supplementation and cardiovascular risk factors reported a modest improvement in insulin resistance as measured by the homeostatic model assessment of insulin resistance, or HOMA-IR. Separately, a systematic review published in 2023 found that vitamin K supplementation was associated with a small reduction in the progression of coronary artery calcification across the randomized controlled trials included in the analysis. These findings are scientifically interesting, but they do not establish that vitamin K2 independently prevents heart attacks, strokes, or cardiovascular deaths.

It is equally important to distinguish evidence concerning different forms of vitamin K, different types of vascular calcification, and different clinical outcomes. Vitamin K1 and vitamin K2 share certain biological functions, but they differ in chemical structure, dietary sources, and aspects of their distribution and metabolism. Similarly, changes in a blood biomarker do not necessarily correspond to meaningful improvements in long-term health.

The central question, therefore, is not simply whether vitamin K2 has biological activity. Rather, it is whether the available evidence demonstrates that increasing vitamin K2 intake or taking a supplement produces reliable, clinically important benefits beyond those achieved through established preventive measures.

This article examines the biological role of vitamin K2, the relationship between vitamin K-dependent proteins and vascular calcification, the evidence concerning insulin resistance, the limitations of current research, and the importance of maintaining a healthy lifestyle. It also considers dietary sources, supplementation, medication interactions, and the priorities for future research. Throughout the discussion, particular attention is given to separating plausible mechanisms and preliminary findings from conclusions that have been demonstrated in human clinical studies.

2. What Is Vitamin K2, and How Does It Differ from Vitamin K1?

Vitamin K is a fat-soluble vitamin required for the normal functioning of several proteins in the human body. The two major nutritional forms are vitamin K1, also known as phylloquinone, and vitamin K2, a group of compounds known as menaquinones.

Vitamin K1 is found predominantly in green leafy vegetables and certain plant oils. Vitamin K2 occurs in several fermented foods and animal-derived products, although the amounts vary considerably depending on the food, its production method, and the microorganisms involved in fermentation. Natto, a traditional Japanese food made from fermented soybeans, is particularly rich in certain forms of vitamin K2. Some cheeses and other fermented foods also contain menaquinones.

Vitamin K2 is not a single chemical compound. Instead, it includes several forms designated MK-4, MK-7, MK-8, MK-9, and others. These compounds differ in the length of their chemical side chains, which can influence their absorption, distribution, and persistence in the circulation.

MK-4 and MK-7 are among the most extensively investigated forms in nutritional research. MK-7 has a relatively long half-life in the bloodstream compared with some other forms of vitamin K, making it an important subject of supplementation studies. MK-4 is present in certain animal-derived foods and can also be produced within the body from vitamin K1 through a conversion process.

These differences matter because findings from a study using one form of vitamin K cannot automatically be applied to every other form. A trial involving vitamin K1, for example, may provide useful information about vitamin K-dependent biological pathways without establishing the effectiveness of vitamin K2 supplementation. Likewise, a study of MK-7 at a particular dose and duration cannot necessarily predict the effects of MK-4 or a combination product containing several nutrients.

According to the National Institutes of Health Office of Dietary Supplements, vitamin K functions as a cofactor for an enzyme involved in the activation of several proteins. These proteins participate in blood coagulation, bone metabolism, and other physiological processes. Vitamin K is therefore essential for normal health, but its presence in the diet does not automatically mean that additional supplementation will produce benefits in people who already obtain adequate amounts.

The distinction between meeting nutritional requirements and taking extra supplements is fundamental. Vitamins are necessary for normal physiological function, but the relationship between intake and health is not always linear. Correcting a deficiency may be beneficial, while increasing intake beyond an adequate level may produce little additional improvement. Whether supplementation is useful depends on factors such as baseline nutritional status, the population being studied, the specific nutrient form, and the outcome being measured.

For vitamin K2, one of the principal scientific questions is whether people with insufficient vitamin K-dependent protein activation can benefit from additional intake. Researchers have investigated this question by measuring circulating forms of MGP and evaluating whether supplementation affects vascular calcification over time.